Navigation Links
Many patients who die while awaiting liver transplant have had donor organs declined
Date:11/5/2012

The majority of patients on the liver transplant waitlist who died received offers of high-quality donated livers that were declined prior to their death, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. Therefore, efforts other than simply increasing the availability of donated livers or the number of offers are needed to substantially reduce the deaths among those waiting for a transplant.

"Our findings suggest that waitlist deaths are not simply due to lack of donor organs, as many of us assume. Rather, deaths result from opportunities for transplantation that were declined," said John P. Roberts, MD, of the University of California San Francisco and lead author of this study. "Efforts should also be made to reduce the stigma associated with non-ideal livers and set realistic expectations for waitlisted candidates."

Researchers analyzed data from the United Network for Organ Sharing (UNOS) registry on all U.S. liver transplantation candidates who were offered livers from Feb. 1, 2005, to Jan. 31, 2010. Candidates were excluded if their Model for End-Stage Liver Disease (MELD) score which is used to prioritize the urgency for liver transplant was less than 15. Of 33,389 candidates for liver transplantation, researchers found that 20 percent died or were removed from the list, and 64 percent received a transplant. Among the subgroup of 6,787 transplant candidates who eventually died or were removed from the waitlist for being too sick, 84 percent had received at least one organ offer. More surprisingly, these candidates received not just one or two, but a median of six liver offers during their time on the waitlist.

"Donor quality/age" was cited as the most common reason for why transplant centers refused the organ. However, when organs considered "high quality" were analyzed, researchers found that 55 percent of transplant candidates who died or were removed from the waitlist before being transplanted had been offered at least one of these high-quality organs. This suggests that data from the UNOS/Organ Procurement Transplantation Network does not accurately or fully capture the true reason why these organs are refused. Understanding the real-time factors involved in these decisions is vital to improving the waitlist process for liver transplant candidates.

In a related editorial, Michael L. Volk, MD, MSc, and Carl L. Berg, MD, state that this study highlights the need to better inform patients about organ offers and to engage them in deciding whether to accept or decline such offers, rather than leaving this decision solely up to their physicians. Although it is assumed that most of these decisions are made with the best intent, it would be of interest to learn of patients' opinions about multiple organs being declined on their behalf.

Patients waiting for a liver transplant are prioritized by their risk of waitlist mortality, which is determined by their MELD score. Once a liver transplant becomes available, it is offered to the candidate who is first on the waitlist. Depending upon the quality of the donor liver relative to the perceived need of the candidate, this liver offer may be accepted for transplantation. However, the center to which the liver was offered can decline the organ, in which case, it will be offered to the candidate who is next on the waitlist, and similarly down the waitlist, until it is finally accepted for transplantation.


'/>"/>
Contact: Alissa J. Cruz
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. Bypass Beats Stents for Diabetic Heart Patients: Study
2. Drug doesnt significantly lower risk of major heart problems in dialysis patients
3. Eating More Fruits, Veggies May Help Kidney Patients
4. Combination treatment may improve survival of breast cancer patients with brain metastases
5. Stem cells show promise for treating infertility in cancer patients
6. Cancer Drug Reduced Relapses in MS Patients: Studies
7. Study: Repeated surgeries appear to extend life of patients with deadliest of brain cancers
8. Patients with diabetes left in the dark
9. Black Breast Cancer Patients May Have Higher Death Risk in First 3 Years
10. Automated calls help patients in under-developed countries manage blood pressure, U-M study finds
11. Controlling depression is associated with improved health for heart-failure patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 26, 2017 , ... RawTrition now brings you BioEnergy which is a powder ... , RawTrition is taking nutrients to the next level! The superfoods ... its raw form (unlike the synthetically made options that are on the market). , ...
(Date:4/25/2017)... ... ... Bellus Medical, a leader in medical aesthetics, recently acquired ... photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated to ... minimize the appearance of pores – all with minimal downtime and results that ...
(Date:4/25/2017)... IN (PRWEB) , ... April 25, 2017 , ... ... D.C., CEOs, CFOs and HR decision-makers are preparing for how his administration could ... Financial will provide insight into what changes are most likely to make it ...
(Date:4/25/2017)... Switzerland (PRWEB) , ... April 25, 2017 , ... ... innovation targets, they rely on contracted partners to help with process innovation in ... of combined drug formulation experience along with state-of-the-art analytical equipment in support of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a leading ... patient care management module. Using this new feature, sleep physicians can now predict ... on continuous positive airway pressure (CPAP), oral, or other forms of sleep apnea ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
(Date:4/19/2017)... -- Cardiology devices segment is anticipated to reach the highest ... Devices segment is likely to create absolute $ opportunity of ... 2017. By the end of 2027, Cardiology Devices segment is ... Mn, expanding at a CAGR of 18.4% over the forecast ... Pacific reprocessed medical devices market in terms of ...
(Date:4/19/2017)... , April 19, 2017 Global Surgical Drainage ... are tubes used to remove excess liquid and air. ... pus, urine, bile or lymph. Surgical drains are used ... such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery ... post-surgery to prevent accumulation of fluid e.g. blood or ...
Breaking Medicine Technology: